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Melton, 1999; Lewis and Tam, 2006). Collectively, these studies
suggest a conserved mechanism for the commitment to endo-
derm/mesoderm, utilizing signaling proteins from the Wnt, fibro-
blast growth factor (FGF), and transforming growth factor
b (TGF-b) families. Similarly, in vitro application of Activin A or
Nodal to mouse or human ESC cultures leads to endoderm
induction (Kubo et al., 2004; Yasunaga et al., 2005; D’Amour
et al., 2005). Other molecules that influence endoderm formation
in vitro include Wnts (D’Amour et al., 2005), bone morphogenic
proteins (BMPs), and members of the AKT/P13K pathway
(McLean et al., 2007).
Permeable small molecules can control cellular processes by
modulating signal transduction pathways, gene expression, or
metabolism and have been effectively used in ESC differentia-
tion protocols. Small molecules can be synthesized in high quan-
tity and purity, as well as conveniently supplied or removed,
giving them great potential to be useful for therapeutic applica-
tions. High-throughput screens have been performed to identify
novel small molecules that can support self-renewal of ESCs
(Chen et al., 2006; Desbordes et al., 2008) and the specification
of cardiomyocytes (Wu et al., 2004) and neural progenitors
(Diamandis et al., 2007; Ding and Schultz, 2004).
We describe here two small molecules, IDE1 and IDE2, that
can efficiently induce definitive endoderm (IDE) from mouse
and human ESCs. Treatment of mouse ESC monolayer cultures
with either compound yields high quantities of endoderm-
expressing multiple endodermal marker genes. We show that
chemically derived endoderm develops into pancreatic progen-
itors in vitro in response to the growth factor FGF10, retinoic
acid, and hedgehog inhibitors, a commonly used combination
to induce pancreatic progenitors in vitro. Moreover, we apply
a recently identified small molecule, Indolactam V (Chen et al.,
2009), which induces pancreatic progenitors in human ESC
culture, to either IDE1- or IDE2-derived endoderm and induce
higher yields of pancreatic progenitors compared to a growth
factor-based approach. Finally, we show that compound-
induced endoderm can contribute to gut tube formation in vivo
when the cells are injected into the developing gut tube of mouse
embryos. All together, we introduce two small molecules that
induce a robust differentiation of ESCs into endoderm that hasSUMMARY
An essential step for therapeutic and research appli-
cations of stem cells is the ability to differentiate them
into specific cell types. Endodermal cell derivatives,
including lung, liver, and pancreas, are of interest
for regenerative medicine, but efforts to produce
these cells have been met with only modest success.
In a screen of 4000 compounds, two cell-permeable
small molecules were indentified that direct differen-
tiation of ESCs into the endodermal lineage. These
compounds induce nearly 80% of ESCs to form defin-
itive endoderm, a higher efficiency than that achieved
by Activin A or Nodal, commonly used protein
inducers of endoderm. The chemically induced endo-
derm expresses multiple endodermal markers, can
participate in normal development when injected
into developing embryos, and can form pancreatic
progenitors. The application of small molecules to
differentiate mouse and human ESCs into endoderm
represents a step toward achieving a reproducible
and efficient production of desired ESC derivatives.
INTRODUCTION
Type I diabetes results from the destruction of insulin-producing
pancreatic b cells, and, therefore, there are several approaches
aimed at cell-based strategies to replace these cells and rejuve-
nate the pancreas. The spontaneous or undirected differentia-
tion of embryonic stem cells (ESCs) produces very small
numbers of insulin-producing cells, barely enough for research
study and far short of the numbers needed for therapeutic appli-
cation. One strategy to increase the efficiency of b cell formation
is to mimic embryonic development by exposing ESCs and their
derivatives to factors that they would normally encounter in vivo.
The starting point for this strategy is differentiating ESCs into
definitive endoderm.
Our understanding of the developmental pathways that
control endoderm formation has so far been guided by studies
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Small Molecules Induced Definitive Endodermthe same or a very similar developmental potential to its in vivo
counterpart. The induction of endoderm from ESCs by IDEs is
conserved between mouse and human species. Though we
have yet to achieve complete stepwise differentiation from
ESCs to pancreatic b cells by chemical means, this study
focuses on an important first step: formation of endoderm.
RESULTS
Screening with ESCs for Endoderm Formation
To obtain a reporter for endoderm formation, we generated
a mouse ESC line with the red fluorescent protein dTomato,
a variant of DsRed (Shaner et al., 2004) coding sequence under
control of the Sox17 promoter (Figure S1 available online).
Several lines of evidence show that Sox17 is an endodermal
marker, both definitive and extraembryonic. A null mutation in
mice is devoid of foregut endoderm, andmid- and hindgut endo-
derm fails to expand (Kanai-Azuma et al., 2002). Gene expres-
sion analysis of isolated endoderm confirms that Sox17 is
Figure 1. High-Throughput Screening
(A) Scheme of differentiation into endoderm and
evaluation of an endoderm reporter line. Treat-
ment with either Activin A or Nodal induces endo-
derm in mouse ESC cultures, and at day 6 of treat-
ment, 45% of total cells are Sox17/dsRed double
positive. Every dsRed+ cell stains positively for
Sox17 antibody.
(B) Overview of the identification of endoderm
inducers from small molecule collection. Out of
>4000 screened compounds, 27 primary hits
were selected and further evaluated for specificity
and toxicity. Markers for definitive endoderm (DE)
and extraembryonic endoderm (EE) were tested
by Q-RT-PCR and immunohistochemistry, and
two compounds that induced high levels of DE
were indentified.R 3 SD = more than three stan-
dard deviations.
a marker of endoderm, both definitive
and extraembryonic (Sherwood et al.,
2007). However, it is important to note
that Sox17 expression is not restricted
exclusively to endoderm; genetic lineage
tracing shows that Sox17 is expressed in
the endodermal lineage as early as E7.5
but later on marks the gut tube as well
as other organs (Park et al., 2006; Kim
et al., 2007; Liu et al., 2007; R.M., unpub-
lished data).
In vitro, application of TGF-b family of
growth factors, including Activin A or
Nodal, to both mouse and human ESC
cultures leads to the preferential differen-
tiation into endodermal lineages (Kubo
et al., 2004; Yasunaga et al., 2005;
D’Amour et al., 2005). Consistent with
those previous studies, we observe
endoderm induction when Sox17-dsRed
mouse ESCs are treated with Activin A
for 6 days in low-serum conditions (see Experimental Proce-
dures). At 6 days, 45% of cells stain positively for Sox17 and
express dsRed (Figure 1A). All dsRed+ cells also express
Sox17 protein as judged by Sox 17 antibody staining, which
shows that the reporter line accurately reflects endogenous
Sox17 expression. The coexpression of the fluorescent marker
and endogenous Sox17 was also confirmed at all time points
in vitro as well as in E6.5 and E7.5 embryos (data not shown).
There is a minor population of cells (10% ± 3.6%) that stained
for Sox17 but did not express dsRed; however, no false positive
expression of the transgene (DsRed positive but Sox17 antibody
negative) was observed.
The endoderm differentiation protocol used in this screen is
based on previously published protocols (Kubo et al., 2004;
Yasunaga et al., 2005; D’Amour et al., 2005) with several modifi-
cations to allow endoderm lineage induction in a high-
throughput format. Specifically, we cultured the mouse ESCs
as amonolayer (in contrast to embryoid bodies) in gelatin-coated
384-well plates without any feeder cell layer. We also adjustedCell Stem Cell 4, 348–358, April 3, 2009 ª2009 Elsevier Inc. 349
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survival of mouse ESCs (see Experimental Procedures for
details).
At 12 hr after plating, Sox17-dsRed mouse ESCs were
supplied with differentiation media (low-serum content), and
a single chemical compound was added by pin transfer. At this
time point (x = 0), no dsRed+ and/or Sox17 antibody reactive
cells were detected. In contrast, nearly all cells expressed
Oct4, a pluripotency marker (data not shown). After day 6 of
culture in the presence of compounds, we evaluated Sox17/
DsRed expression and total cell number by flow cytometry.
More than 4000 compounds were tested from a small mole-
cule collection consisting of known compounds that influence
stem cell fate (such as retinoic acid and 5-azacytidine), bioactive
compounds, compounds with known activity in signaling path-
ways, US Food and Drug Administration-approved drugs, and
a histone deacetylase (HDAC) inhibitors-biased small molecule
library resulting from diversity-oriented synthesis.
Positive hits were defined as compounds that induce expres-
sion of Sox17/dsRed at three standard deviations above the
DMSO (vehicle) control and were not autofluorescent or cyto-
toxic (Figure 1B). Effects on cell viability or toxicity were set by
requiring that the number of cells after 6 days of culture doubled,
i.e., reached at least 1600 cells/well. Activin A treatment was
used as a positive control. The effects of various treatments on
differentiation were first evaluated by flow cytometric analysis
for dsRed-expressing cells and later confirmed by Sox17 and
FoxA2 immunofluorescence and quantitative RT-PCR (Q-RT-
PCR) analysis of endodermal markers, including Sox17, FoxA2,
Gata4, Gata6, a-fetoprotein (Afp), and Sox7. Twenty-seven
compounds, 0.7% of total screened compounds, were
selected as primary hits and further characterized. We also
tested for the expression of ectodermal genes, including Sox1,
Pax6, Zic1, and mesodermal markers Pdgfr-a, Pdgfr-b, and
Meox1 by Q-RT-PCR (data not shown) to ensure specificity.
Finally, because propensity to form different germ layer cell
types varies between different mouse and human ESC lines
(Burridge et al., 2007; Osafune et al., 2008), we tested primary
hits by using three mouse ESC lines of two different genetic
backgrounds (129 and 129/C57BL6 hybrid). Considering all of
these criteria, two small molecules, IDE1 and IDE2, were identi-
fied out of the 27 primary hits as inducers of endoderm and were
selected for further studies (Figure 1B).
Induction of Definitive and Extraembryonic Endoderm
During evaluation of primary hit compounds, we observed that
small molecules induced Sox17+ cells with two distinct morphol-
ogies. One class, including IDE1 and IDE2, induced clustered
populations of Sox17+ cells, whereas other compounds led to
the formation of a dispersed population of Sox17+ cells (Fig-
ure S2A). A third class of compounds induced cells with a mixed
morphology. Sox17 is expressed in definitive endoderm but also
in extraembryonic endoderm and in other germ layer derivatives
at later stages of development, including vascular endothelium
(Kanai-Azuma et al., 2002;Matsui et al., 2006). Because the posi-
tive identification of definitive endoderm is hindered by the lack
of unique markers that are expressed exclusively there and are
not present in other types of endoderm, we performed a negative
selection and tested for markers of extraembryonic endoderm.350 Cell Stem Cell 4, 348–358, April 3, 2009 ª2009 Elsevier Inc.We found that the vast majority (>95%) of the dispersed
Sox17+ cells (class II) also expressed extraembryonic endoderm
markers, including Gata4 (Morrisey et al., 1996), SPARC (Mason
et al., 1986), AFP (Dziadek, 1979), and Dab2 (Yang et al., 2002)
(Figure S2B). Conversely, Sox17+ cells induced by treatment
with either IDE2 (Figure S2B) or IDE1 (data not shown) formed
clustered, epithelial-like populations and contained no or a negli-
gible number of cells that were positive for extraembryonic
markers (Figure S2B).
Optimization of Definitive Endoderm Induction by Active
Compounds
IDE1 and IDE2 are products of de novo chemical synthesis and
come from a library of putative HDAC inhibitors (Figure 2A). Titra-
tion of IDE1 and IDE2 from 50 nM to 5 mMshowed that they func-
tion in a dose-dependent manner (EC50 = 125 nM for IDE1 and
EC50 = 223 nM for IDE2) (Figure 2A), with the highest efficiency
and no toxicity in the 250–800 nM range. The optimal concentra-
tion of IDE1 induces Sox17 expression in 80% and IDE2 in 72%
of total ESCs at day 6 of treatment (Figure 2B). We also tested for
the expression of FoxA2 (also known as HNF3b) as an essential
gene for the development of the definitive endoderm in mouse
(Ang et al., 1993; Monaghan et al., 1993; Sasaki and Hogan,
1993) and observed that more than 95% of compound-induced
Sox17+ cells coexpress FoxA2 (Figure 2B).
IDE1 and IDE2 Induce Endoderm from Human ESCs
Then, we tested whether the hit compounds have the ability to
direct also human ESCs (HUES) into endodermal fate. Two
HUES lines, HUES 4 and 8, treated with IDE compounds show
propensity to differentiate into endodermal lineage (Osafune
et al., 2008) as judged by Sox17 expression. Both compounds
induced Sox17 expression in a dose-depended manner. Treat-
ment with IDE1 (100 nM) for 4 days leads to Sox17 expression
in 62% ± 8.1% of cells (Figure 2C), an efficiency similar to Activin
A treatment in these culture condition (64% ± 6.3%) (Figure S3).
IDE2 (200 nM) induces Sox17 expression in 57% ± 6.7% of total
cell number (Figure 2C), and the effect of IDE2 is significantly
different (p = 0.00255) compared to the mock treatment
(16% ± 3.6%), albeit slightly below the Activin A efficiency (Fig-
ure S3). The majority (R90%) of Sox17+ cells also coexpressed
another endodermal marker, FoxA2 (Figure 2C). Cotreatment of
HUES cells with Activin A and Wnt3a increases the efficiency of
endoderm induction only by an additional 3%–5%. A similar effi-
ciency of endoderm induction was observed when HUES were
cultured in the presence of MEF layer or on gelatin-coated
plates.
Time Course and Synergy between Active Compound
and Growth Factors
Endoderm induction from mouse ESCs peaks at day 6 of treat-
ment with small molecules, when 81% ± 14% (for IDE1 treat-
ment) and 76% ± 14% (for IDE2) out of the total cell number
were Sox17+ (Figure 3A). In the course of the next 8 days, the
efficiency of endodermal induction does not significantly
change. Compared to Activin A treatment, both small molecules,
under the conditions reported here, induced more cells to
express Sox17 and did so at earlier time points. The percentage
ofmouse cells expressing Sox17 after 2 day treatment is 34% for
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Small Molecules Induced Definitive EndodermFigure 2. Two Small Molecule Inducers of
Endoderm in Mouse and Human ESC
Cultures
(A) Chemical structure of IDE1 and IDE2 that
induce endoderm from mouse ESCs. The lower
panel shows dose response curves of Sox17
expression (based on immunofluorescence)
following treatment with compound for 6 days.
The EC50 values and curve fitting were performed
with Graph Prism software. Data are presented as
mean ± SD. n = 4.
(B) Representative images of aSox17 immunofluo-
rescence show the highest Sox17 induction in
mouse ESCs by compound at day 6 of treatment,
quantified as the percent of cells expressing
Sox17 (upper panel) out of the total cells. The
majority of Sox17+ cells (R95%) induced by
chemical treatment coexpress another definitive
endoderm marker, FoxA2.
(C) HUES cell cultures were treated for 6 days with
IDE1 or IDE2. The endoderm markers Sox17 and
FoxA2 were analyzed by immunofluorescence.
Treatment with either compound leads to Sox17
expression in 55%–65% of total cells; R95% of
Sox17+ cells coexpress FoxA2.Cell Stem Cell 4, 348–358, April 3, 2009 ª2009 Elsevier Inc. 351
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Small Molecules Induced Definitive EndodermFigure 3. Time Course of Endoderm Induction and Synergy between
Compound and Growth Factors
(A) The effect of compounds on the number of Sox17+ and total cells during
14 days of treatment is shown. Endoderm induction by IDE1 and IDE2 peaks
at about day 6, and as little as 12 hr of treatment with either compound is suffi-
cient to induce Sox17 expression in 40% of the cells. Activin A treatment
induces significant but lower percentage of Sox17+ cells at all tested time
points. Cells were analyzed at day 6 (for earlier time points) or day 14 of culture.
(B) The combined effect of compounds and growth factors on Sox17 expres-
sion. Cotreatment of mouse ESCs with compounds and Nodal enables short-352 Cell Stem Cell 4, 348–358, April 3, 2009 ª2009 Elsevier Inc.IDE1 (Figure 3A) and 32% for IDE2, whereas Activin A yielded
13% Sox17+ cells (Figure 3A); after 4 day treatment, 40%–
50% of cells treated with either of the compounds are Sox17+,
whereas only 28% of Activin A-treated cells are Sox17+.
Simultaneous treatment of mouse ESCs with both IDE1 and
IDE2 did not produce any synergistic effect on Sox17+ induction
(Figure 3B). Cotreatment with IDE2 and Nodal significantly (p%
0.001) increases the Sox17 induction at day 4 to 55.8%± 6.49%,
compared to 42% ± 3.83% with the compound alone. Wnt3a
has no significant effect on Sox17 expression when combined
with compounds.
Gene Expression Analysis of Endoderm Induced
by Active Compounds
Todeterminewhether other genes that compose part of an endo-
dermal signature are induced inmouse ESC cultures treatedwith
active compounds, we isolated Sox17-DsRed+ cells by flow
cytometry after day 6 of compound stimulation and profiled
them with gene expression analysis. Of 19 genes previously
defined as a definitive endoderm signature in the mouse (Sher-
wood et al., 2007), 14 were induced more than 2-fold in the
compound-treated samples compared to mock treatment (Fig-
ure 4A). We also compared in vitro-derived endoderm with its
in vivo counterparts sorted out from Sox17-DsRed E7.5–E8.5
embryos. Of these 19 endoderm signature genes, only 2, Spink3
and Tmprss2, were significantly different and were expressed at
higher levels in the E7.5 endoderm (Figure 4A). Furthermore, we
did not observe any significant changes in the expression of
markers characteristic for other cell lineages, such as the ecto-
derm markers Zic1 and Pax6 and mesoderm markers Flk1 and
CD31 (data not shown) after compound treatment. The r2 value
(square of linear correlation coefficient) between chemically
induced endoderm and Sox17/dsRed+ endoderm isolated from
mouse E7.5–E8.0 embryos was 0.94–0.97 in three independent
experiments (Figure 4B). In contrast, the r2 value for nontreated
mouseESCandnaive endoderm isolated formE.75–8.0 embryos
was0.5–0.56 (Figure 4B). Thesedata suggest that in vitro-derived
endoderm by hit compound treatment is essentially equivalent
to E7.5–E8.0 endoderm with respect to the expression of key
endodermal markers.
Activation of Nodal/Smad Signaling in Sox17+ Cells
Produced by Treatment with Small Molecules IDE1
and IDE2
Genetic and biochemical studies point to Smad proteins as the
intracellular transducers of TGF-b signaling, including Activin A
and Nodal (Whitman, 1998), and a high level of Smad2 phos-
phorylation is detected in cell lysates of ESCs that have been
treated with Activin A or Nodal treatment. Both IDE1 and IDE2
induce phosphorylation of Smad2 after 24 hr or longer at levels
comparable to those induced by Activin A treatment (Figure 5A).
This phosphorylation of Smad2 is strongly attenuated by co-
treatment of mouse ESCs with either of the compounds and
ening of the treatment time and leads to the induction of Sox17 with slightly
higher efficiency: 55.6% at day 4. No synergy was observed between IDE1
and IDE2 or for the combination of either compound with Wnt3a. All quantifi-
cations were based on the percentage of cells stained by Sox17 antibody
out of total cell. Data are presented as mean ± SD. n = 4.
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(A) Expression of definitive endodermal markers in Sox17+ cells induced by compound treatment or isolated from E7.5–8.0 embryos. Sox17/dsRed+ cells were
sorted by FACS, and expression of endoderm genes was analyzed by Illumina microarray. Expression of ‘‘endoderm signature’’ genes normalized to the DMSO-
treatedmouse ESCs is shown. Out of 17 genes, only 2, Spink3 and Tmprss2 (marked by gray circle), were expressed at significantly higher levels (>2-fold change)
in Sox17+ cells isolated from E7.75 embryos (endoderm). Each bar represents an average of three biological replicates, and mean ± SD is shown.
(B) Scatter plots comparing the global gene expression in Sox17/dsRed+ populations sorted out from Sox17/dsRed E7.75 embryos and derived either in vitro
by treatment with IDE2 (day 6 of treatment) or with nontreated mouse ESC cultures. Red line in the middle visualizes the equivalent levels in gene expression;
two-side red lines show 2-fold change in gene expression levels between both samples.Treatment with either of the compounds for 6 hr leads to upre-
gulation of Nodal transcripts by 6- to 8-fold compared to the
control (Figure 5B), and the levels of Nodal expression increase
further with time of compound exposure. Nodal treatment
increases its own expression at similar levels and time schedule.
This may reflect an autoregulatory mechanism for maintainingthe Activin receptor-like kinase 4/5/7 (ALK) inhibitor, SB43125.
Under these conditions, induction of Sox17 protein is also
reduced to 5.6% ± 1.3% (data not shown). These data indicate
that both IDE1 and IDE2 function by activating the TGF-b-
signaling pathway; however, the specific biochemical targets
of these small molecules are unknown.Cell Stem Cell 4, 348–358, April 3, 2009 ª2009 Elsevier Inc. 353
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dependent autoregulatory loop that feeds onNodal transcription
(Agius et al., 2000; Pogoda et al., 2000).
In Vivo Competency of Chemically Derived Endoderm
For chemically derived endoderm to be useful, it is important to
determine its developmental potential beyond the expression of
endodermal markers. The ultimate goal is to direct the cells to
form functional b cells. To begin to address this possibility and
the functional potential of derived populations, we induced
mouse ESCs ubiquitously expressing enhanced yellow fluores-
cent protein (EYFP) (Hadjantonakis et al., 2002) to form endo-
derm with IDE1, IDE2, or DMSO (control). At day 6 of treatment,
we dissociated and injected the cells into the gut tube (a deriva-
tive of endoderm) of live E8.75 embryos. The lumen of the gut
tube can be accessed prior to the completion of embryonic
Figure 5. Small Molecule Inducers of Endoderm Activate TGF-b
Signaling
(A) Phosphorylation of Smad2 was analyzed in lysates of ESCs treated with
IDE1, IDE2, DMSO, Activin A, or Nodal or in the presence of the ALK4/5/7
inhibitor SB431542. Treatment with IDE1 or IDE2 leads to activation of the
TGF-b pathway after 24 hr, similar to either Nodal or Activin A treatment. Phos-
phorylation of Smad2 by either of the two compounds is significantly attenu-
ated in the presence of SB431542.
(B) Increase in Nodal expression after treatment with small molecules IDE2,
IDE1, and Nodal. Relative expression over DMSO treatment is shown as
a mean of triplicate experiments ± SD.354 Cell Stem Cell 4, 348–358, April 3, 2009 ª2009 Elsevier Inc.turning and gut tube closure and, therefore, provides a develop-
mental window for functional assessment of ES-derived endo-
derm cells. Chemically derived endoderm was injected into the
primitive gut tube at the anterior and posterior intestinal portals.
At this time, the gut tube is still open, and anterior intestinal portal
is accessible (A.E.C. and D.A.M., unpublished data, and
Figure 6A). We culture the embryos ex vivo for 24–30 hr, during
Figure 6. Functional Evaluation of Chemically Derived Endoderm
(A) Scheme of in vivo assay to assess the functional potential of compound-
induced endoderm. Mouse ESCs treated with chemical inducers incorporate
into the developing host gut tube. Cultures of mouse ESC reporter lines ex-
pressing constitutive YFP were differentiated into endoderm with IDE1 or
IDE2, producing 60%–70% Sox17+ cells, and then trypsinized and injected
into the nascent gut lumen of E8.75 mouse embryos. Dashed line shows an
approximate plane of section.
(B) After 24–30 hr ex vivo culture, mouse embryos were fixed, transversally
sectioned, and stained with antibodies against FoxA2 and Cldn6 to detect
gut epithelial cells and anti-YFP antibodies to visualize injected cells. IDE1
and IDE2 induced endodermal cells incorporate into gut tube and show
expression of gut tube markers. In contrast, DMSO-treated cells remain clus-
tered in the gut tube lumen 30 hr after injection and do not incorporate into the
gut epithelia or express gut tube markers.
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and the gut tube closes—around E9.5. ES-derived endodermal
cells induced by small molecules integrated into the developing
gut tube, whereas control-treated ESCs did not. Moreover, ESC
derived expressed markers of gut tube FoxA2 and Claudin6 and
showed the characteristic morphology of gut cells (Anderson
et al., 2008) (Figure 6B). Cells induced by IDE1 treatment inte-
grated into the gut in 8 out of 35 cases and in 7 out of 29 embryos
for IDE2. Conversely, DMSO (control)-treated cells never inte-
grate into the developing gut tube (0 out of 10 and 0 out of 11,
respectively) and instead remain in the lumen (Figure 6B).
In Vitro Potential of Compound-Induced Endoderm
To further evaluate the developmental potential of compound-
induced endoderm, we tested whether it can differentiate
in vitro into pancreatic progenitors. Pancreatic progenitors
appear in the pancreatic bud at E9.5 and are marked by the
expression of the transcription factor Pdx1. Pdx1 is required
for pancreas development and b cell formation because a null
mutation of Pdx1 in mice results in a failure to form a pancreas
(Jonsson et al., 1994; Offield et al., 1996), and lineage tracing
studies show that Pdx1 marks progenitors that give rise to all
pancreatic cell types (Gu et al., 2003). Using Pdx1-GFP knockin
(Micallef et al., 2005) mouse ESCs, we induced definitive endo-
Figure 7. Developmental Potential of
Chemically Derived Endoderm
(A) Scheme of mouse ESC differentiation into
Pdx1+ pancreatic progenitors. Endoderm was
first derived through treatment with either IDE1
or IDE2, and then formation of pancreatic progen-
itors wasmonitored using a Pdx1-GFPES reporter
line.
(B) Endoderm-enriched cultures were grown for
another 6 days in chemically defined media con-
taining: DMSO without any additional growth
factors or compounds (control), in the presence
of growth factors (FGF10, CYC, RA), or in the pres-
ence of Indolactam V to induce the expression of
Pdx1. At day 12, in cultures treated initially with
IDE1 or IDE2 and followed by ILV, 50% of the total
cells were Pdx1+, a 10-fold increase above control
treatment.
derm using either of the hit compounds
and cultured cells in various conditions
for an additional 6 days.
Published protocols for differentiation
of ESCs into pancreatic progenitors are
based on studies of the factors that
modulate signaling during pancreatic
organogenesis (Stafford and Prince,
2002; Lau et al., 2006; Bhushan et al.,
2001). For example, in one protocol,
endoderm is induced with Activin A,
followed by treatment with FGF10 and
the Hedgehog signaling inhibitor KAAD-
cyclopamine for 3 days, and is then
exposed to a posteriorizing factor, reti-
noic acid, for an additional 3 days to
induce Pdx1 expression (D’Amour et al., 2006). Using this
regimen, 12.1% ± 4% of the mouse ESCs differentiate further
into pancreatic progenitors, defined by Pdx1+ expression. By
comparison, when compound-induced endoderm was used as
a starting population, rather than Activin A-induced endoderm,
25% ± 6% of cells expressed Pdx1. Spontaneous differentiation
in the absence of hit compounds, additional growth factors, or
signaling modulators occurs at a lower level, producing GFP
expression in 4.6% ± 1.1% of cells (Figure 7).
Finally, a separate chemical screen performed using human
cells has identified a compound, Indolactam V (Chen et al.,
2009), that can induce pancreatic progenitors from endoderm
that has been produced from HUES. Indolactam V is also able
to efficiently induce pancreatic progenitors (Pdx1+ cells) in
endoderm derived by chemical treatment of mouse ESC. Treat-
ment of IDE1- or IDE2-induced mouse endoderm yields 51% ±
7.4% Pdx1-GFP-expressing pancreatic progenitors at day 6
(Figure 7). When cultures were stained with Pdx1 antibodies,
we observed a similar number (53% ± 6.4%) of positive cells
after two-step treatment with small molecules. Notably, this is
a 10-fold increase in cell number compared to the control
DMSO treated and a 4-fold increase compared to published
protocols. The majority of Pdx1+ (92% ± 5%) cells also express
other pancreatic progenitor markers, including HNF6 (Figure S4).Cell Stem Cell 4, 348–358, April 3, 2009 ª2009 Elsevier Inc. 355
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in vitro generation of pancreatic progenitors that utilizes the
small molecules at each step, first as inducers of endoderm
and later to generate pancreatic progenitors.
DISCUSSION
The directed differentiation of ESCs into therapeutically useful
cell types has received much attention because of the potential
to study and possibly treat a number of diseases. One promising
differentiation strategy is to recapitulate, in vitro, the develop-
mental signals that guide cells down specific lineages during
development. A complementary approach is to identify cell-
permeable small molecules that direct differentiation toward
specific cell fates. As an example of this latter approach, the
chemical screen described here shows that it is possible to
induce definitive endoderm formation from mouse ESCs in vitro.
We found two potent small molecules, IDE1 and IDE2, that can
direct mouse ESCs differentiation such that 70%–80% of cells
are endoderm cells. Both compounds are products of de novo
synthesis, and their biological activity has not been previously re-
ported. This efficiency of induction compares favorably with
published protocols employing TGF-b family members, e.g., Ac-
tivin A or Nodal, which produce about 45% endoderm. In addi-
tion, both IDEs induce endoderm formation also in HUES
cultures, therefore providing new tools for ESC-directed differ-
entiation. In the long term, the potential benefits of finding chem-
icals like IDE1 or IDE2 include the prospect of minimizing the risk
of animal disease infections and a cost reduction for materials
and the temporal control that can be achieved using small mole-
cules that can be easily delivered and removed. Application of
either of the two small molecules reported here does not elimi-
nate the necessity of serum presence in the differentiation proto-
cols. Our results enhance the repertoire of chemical compounds
for manipulating ESC fate and encourage the high-throughput
screening of small molecules to direct differentiation of ESCs
under chemically defined conditions.
With respect to their potential to induce endoderm, IDE1 and
IDE2 appear to be interchangeable because we did not observe
any substantial differences as far as efficiency, gene expression,
or functional potential between populations induced by the two
compounds. Both compounds are novel, and their specific bio-
logical targets remain to be identified, but a strong hint comes
from the fact that they activate part of a TGF-b pathway as evi-
denced by Smad2 phosphorylation.
In the experiments reported here, mouse ESCs were cultured
in the absenceof feeders or other supportive cell types.However,
extrinsic signaling could well improve the efficiency of the differ-
entiation andmaturation of cells. Interactionsbetweenendoderm
and different mesodermal cell types pattern the gut epithelium
into progenitor domains and promote local organ outgrowth
(Horb and Slack, 2001; Deutsch et al., 2001; Kumar et al.,
2003). One source for prospective inductive signals is pancreatic
mesenchyme, which supports budding of dorsal pancreatic
tissue into the stroma (Golosow and Grobstein, 1962; Wells and
Melton, 2000). Another important signal comes fromvessel endo-
thelium, which provides inductive signals for islet development
(Lammert et al., 2001). Future studiesmay identify smallmolecule
substitutes for these developmental signals.356 Cell Stem Cell 4, 348–358, April 3, 2009 ª2009 Elsevier Inc.If in vitro differentiation of ESCs is to be used for treating
human diseases, including diabetes, it will likely require the deri-
vation of large quantities of cells with high purity in chemically
defined conditions. This study shows the feasibility of chemical
screening to identify molecules that may achieve this effect—in
this case direct ESCs into endoderm, which is relevant for liver,
lung, stomach, intestine, and thymus, as well as the pancreas.
EXPERIMENTAL PROCEDURES
Mouse ESC Culture and Differentiation
Mouse ESCs were routinely cultured on irradiated CF-1 MEF feeder cells in
DMEM (GIBCO) media supplemented with 15% fetal bovine serum (HyClone
FBS, Invitrogen), 2 mM L-glutamine (L-Glu, GIBCO), 1.1 mM 2-mercaptoetha-
nol (GIBCO), 1 mM nonessential amino acids (GIBCO), 1 3 penicillin/strepto-
mycin (P/S, GIBCO), and 53 105 units LIF (Chemicon). Cells were passaged at
the ratio of 1:6–1:12 every 2–3 days using 0.25% trypsin. To generate the start-
ing population, we cultured mouse ESCs on MEF feeder cells until they
reached 80%–90% confluence. Prior to differentiation, ESCs were passaged
onto gelatin-coated plates for 30 min to remove MEFs, and afterwards,
ESCs were seeded at 2500 cells per cm2 on gelatinized plates. After overnight
culture, cells were exposed to 25 ng/ml Wnt3a (R&D Systems) + 50 ng/ml Ac-
tivin A (R&D Systems) or 100 ng/ml Nodal (R&D Systems) in Advanced RPMI
(GIBCO) supplemented with 1 3 L-Glu and 0.2% FBS (GIBCO) for 1 day,
then Activin A or Nodal in the same media, and then cultured for 4–6 days to
induce endoderm differentiation. For the chemical inductions, IDE1 and IDE2
(provided by S.L.S.) were added at 5 mM concentration in the differentiation
media. For pancreatic progenitors induction, the cells were transferred to
50 ng/ml FGF10 (R&D Systems), 0.75 mM KAAD-cyclopamine (Calbiochem),
and 2 mMRA (Sigma) or 330 nM IndolactamV (Axxora) in DMEMsupplemented
with 1 3 L-Glu, 1 3 PS, and 1 3 B27 (Invitrogen) for 4 days. SB431542 was
purchased from Sigma. All stock compounds were made with either DMSO
or PBS.
High-Throughput Screen
To carry out the screen, mouse Sox17/dsRed ESCs (passage 16–20) were
trypsinized, MEF depleted, and plated on gelatin-coated 384-well plates at
density 800 cells/well using Biotek mFill. After overnight incubation in regular
mouse ES media, the media was changed to low serum containing differenti-
ating media (2% FBS), and compounds were added by pin transfer at final
concentration 5 mM in a volume 50 ml per well containing 0.1% DMSO (v/v).
After an additional 6 days of culture, cells were washed with PBS, trypsinized
for 3 min, and suspended in FACS buffer (PBS, 5% FBS), and dsRed expres-
sion was detected by high-throughput FACS analysis (Aria, Becton Dickinson).
Chemical Libraries
The compound libraries used for this study included: the MicroSource library
consisting of 2000 bioactive compounds and known drugs; 1000 synthetic
compounds biased for HDAC inhibition (obtained from S.L.S. laboratory);
a selection of hand-picked known modulators of stem cell fate (20
compounds); and small molecule microarray consisting of 400 compounds,
including bioactives, natural products, and 400 compounds that are known
modulators of development or signaling pathways (both prepared by S.L.S.
laboratory).
HUES Cells Culture and Differentiation
HUES cell lines were cultured essentially as described Cowan et al., 2004. In
brief, HUES4, HUES8, and HUES9 cells were routinely cultured on irradiated
CF-1 MEF feeder cells in KnockOut DMEM (GIBCO) supplemented with
10% KnockOut Serum Replacement (GIBCO), 10% human plasma (Invitro-
gen), 2 mM L-Glu (GIBCO), 1.1 mM 2-mercaptoethanol (GIBCO), 1 mM nones-
sential amino acids (GIBCO), 13P/S (GIBCO), and 10 ng/ml bFGF (Invitrogen).
Cells were split at the ratio of 1:10–1:12 every 4–5 days using 1 mg/ml collage-
nase type IV. To induce endoderm formation, we cultured HUES cells on MEF
feeder cells until 80%–90%confluent and then treatedwith 100 ng/ml Activin A
in advanced RPMI (GIBCO) supplemented with 1 3 L-Glu and 0.2% FBS
(GIBCO) or with a combination of 25 ng/ml Wnt3a (R&D systems) + 100 ng/ml
Cell Stem Cell
Small Molecules Induced Definitive EndodermActivin A (R&D systems) or were exposed to compounds in the samemedia. At
days 4 or 6 of culture, cells were analyzed for endodermal marker expressions
Sox17 and FoxA2.
Immunocytochemistry
Cells were fixed in 4% paraformaldehyde (PFA, Sigma) in PBS for 20 min at
4C followed by a wash with PBS. Cells were blocked with 10% donkey serum
(Jackson Immunoresearch) in PBS/0.1% Triton X and incubated with primary
antibodies overnight at 4C. Secondary antibodies were incubated for 1 hr at
room temperature. The following antibodies and dilutions were used: goat
anti-SOX17 (1:500, R&D systems); rabbit anti-PDX1 (1:200, Chemicon), rabbit
anti-FoxA2 (1:500, Upstate), rabbit anti-Dab2 (1:200, Santa Cruz), rabbit anti-
SPARC (1:200, Santa Cruz,), mouse anti-AFP (1:100, Sigma), anti-Gata6 (1:50,
Santa Cruz Biotech), goat anti-HNF6 (1:200, Santa Cruz Biotech), rabbit anti-
RFP/DsRed (1:300, MBL), and rabbit anti-GFP (1:200, Molecular Probes).
Secondary antibodies were: rhodamine Red-X-conjugated donkey anti-goat
antibody (1:200, JIRL), Alexa-488-conjugated goat anti-mouse, and Alexa-
594-conjugated goat anti-rabbit antibodies (1:300, Molecular Probes). Nuclei
were visualized by Hoechst 33342 (1:1000, Molecular Probes). Images were
taken using an Olympus IX70 Microscope. For quantification, images were
analyzed for the frequency of Sox17+, FoxA2+, or Pdx1+ cells using Meta-
morph image analysis software (Molecular Devices), and at least six images
per well were collected. Data were confirmed in four independent experi-
ments.
Flow Cytometry
Cells were dissociated using 0.25% trypsin for 3min, followed by quenching of
trypsin, and further dissociation in PBS with 5% FBS. Suspension was filtered
through nylon, and cells were analyzed and sorted out by MoFlo (Dako Cyto-
mation, Ft. Collins, CO).
Quantification of Endoderm Formation
Endoderm formation was monitored by Sox17 expression by either flow
cytometry detection of Sox17/DsRed or immunofluorescence using anti-
Sox17 antibodies. Cells labeled by antibody staining were quantified using
Metamorph software as percentage of total cell number (based on Hoechst
33342 nuclei staining). All conditions were tested in either tri- or quadrupli-
cates.
Global Gene Expression Analysis
Sox17/DsRed+ cells were sorted out by FACS from mouse ESC cultures
treated either with growth factors or compounds. Total RNAwas isolated using
Qiashredder and RNAeasy Mini Kit (both from QIAGEN). Biotinylated cRNA
was prepared from R 100 ng of isolated RNA using Illumina TotalPrep RNA
Amplification Kit (Ambion) and hybridized to the Illumina mouse genome
Bead Chips (MouseRef8). All samples were prepared as three biological repli-
cates. Data were acquired with Illumina Beadstation 500 and were evaluated
using BeadStudio Data Analysis Software (Illumina).
Western Blot Analysis
Cells were lysed in 1 3 RIPA lysis buffer in the presence of protease inhibitor
mixture (Roche)/1% phosphatase inhibitor mixture (Roche). Proteins were
separated by 10% Tris-Glycine SDS/PAGE (Bio-rad) under denaturing condi-
tions and transferred to a nitrocellulose membrane. After blocking with 5%
skim milk in PBS/0.1% Triton X, the membrane was incubated with antibodies
against phospho-Smad2 (1:1000, Cell Signaling) or b-actin overnight at 4C.
The membrane was then washed, incubated with anti-mouse/rabbit peroxi-
dase-conjugated secondary antibody (1:1000, Cell Signaling) at room temper-
ature for 1 hr, and developed by SuperSignal chemiluminescence (Pierce).
Injections into Gut Tube and Embryo Culture
Mouse E8.5 ICR embryos were dissected in Hanks balanced salt solution and
cultured in the DMEM/F12 (Invitrogen) media supplemented with 50% rat
serum (Valley Biomedical), 1 3 P/S, and L-Glu at 37C for 20–24 hr. The
YFP mouse ESCs were cultured in the presence of IDEs for 6 days to induce
endoderm formation, cells were dissociated with trypsin, and 100,000 cells
were injected into gut tube of E8.75 embryos. Following injections, embryos
were transferred to rotating bottle culture unit and were then cultured in media(1.5–2 ml per embryo) as above under humidified conditions at 40% O2, 5%
CO2, 55% N2, and 37
C. After 30 hr culture, embryos were fixed in 4% PFA/
PBS and embedded in tissue-tek, and cryosections were stained with anti-
bodies against Cld6, FoxA2, and YFP.
SUPPLEMENTAL DATA
Supplemental Data include four figures and can be foundwith this article online
at http://www.cell.com/cell-stem-cell/supplemental/S1934-5909(09)00017-4.
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